Pfizer INC (PFE) Shareholder Cibc World Markets Corp Increased Stake

May 16, 2018 - By Theresa Judd

Pfizer Inc. (NYSE:PFE) Corporate LogoBig Money Sentiment increased to 1.06 in Q4 2017. It has change of 0.10, from 2017Q3’s 0.96. The ratio is positive due to PFE positioning: 51 sold and 675 reduced. 134 funds bought stakes and 632 increased stakes. Investors holded 4.06 billion in 2017Q3 but now own 4.07 billion shares or 0.28% more. Adams Diversified Equity Fund Inc owns 702,940 shs. Winch Advisory Ser Lc has 42,202 shs. Freestone Hldgs Lc holds 0.38% of its capital in Pfizer Inc. (NYSE:PFE) for 149,999 shs. Narwhal Mngmt reported 171,030 shs or 1.42% of all its holdings. Hudson Valley Inv Advisors Adv reported 167,624 shs or 1.5% of all its holdings. Moreover, Veritable Limited Partnership has 0.24% invested in Pfizer Inc. (NYSE:PFE). Eidelman Virant Cap accumulated 2.63% or 123,930 shs. Aviance Cap Mngmt Limited Liability Company reported 121 shs or 0% of all its holdings. Lpl Fincl has 1.58M shs for 0.17% of their capital. Birinyi Assocs reported 18,250 shs. Wealthfront invested in 0.07% or 178,466 shs. Nbt Bancorporation N A reported 201,356 shs or 1.15% of all its holdings. Balyasny Asset Mngmt Lc has invested 0.04% of its capital in Pfizer Inc. (NYSE:PFE). Perkins Management owns 57,934 shs or 2.02% of their US capital. Psagot Investment House holds 0.29% or 183,235 shs in its capital.

PFE had 13 sales and 0 insider buys since December 15, 2017. This’s net activity of $17.75 million. Dolsten Mikael sold $2.55M worth of stock or 69,699 shs. The insider HILL CHARLES H sold $986,292. 1,758 shs were sold by CORNWELL W DON, worth $64,679. On Monday, February 26 $1.24M worth of stock was sold by SUSMAN SALLY. On Tuesday, March 13 the insider LANKLER DOUGLAS M sold $1.84 million. 9,510 shs were sold by LUND-JURGENSEN KIRSTEN, worth $353,677 on Saturday, February 24.

According to 2017Q4 Securities and Exchange form the Cibc World Markets Corp increased its stake in Pfizer Inc (PFE) by 2.58%. The company’s stock declined 3.13% with the market as Cibc World Markets Corp bought 133,695 shares. The health care company reported $192.62 million value for the 2017Q4. Now the institutional investor is holding 5.32M shares, compared to the 5.18M from the previous quarter. Pfizer Inc has $209.44B MC. The stock increased 0.32% or $0.115 during the last trading session, reaching $35.805.Pfizer Inc. has volume of 7.95 million shares. Since May 16, 2017 PFE has risen 2.43% and is uptrending. The stock underperformed the S&P 500 by 9.12%.

According to a filing Cibc World Markets Corp decreased its stake in Ameren Corp Com (NYSE:AEE) by 194,149 shares to 91,390 shares, valued at $5.39 million in 2017Q4. The fund operates about $13.92 billion US Long portfolio. Cibc World Markets Corp has cut its stake in Charter Communications Inc D Cl A (NASDAQ:CHTR) and also reduced its holding in Cimarex Energy Co (NYSE:XEC) by 42,381 shares in the quarter, for a total of 58,000 shares.

For more Pfizer Inc. (NYSE:PFE) news published recently go to:,,, or The titles are as follows: “Pfizer (PFE) Announces FDA Approval for Biosimilar RETACRIT” published on May 15, 2018, “Pfizer Is A Definite Buy For 2018” on April 30, 2018, “Pfizer: Buy This Dip?” with a publish date: May 03, 2018, “What to Look For in the Merck and Pfizer Reports Tuesday Morning” and the last “Better Buy: Pfizer Inc. (PFE) vs. Merck (MRK)” with publication date: May 13, 2018.

Pfizer Inc. (NYSE:PFE) Ratings Coverage

In total 9 analysts cover Pfizer (NYSE:PFE). “Buy” rating has 3, “Sell” are 1, while 5 are “Hold”. (NYSE:PFE) has 33% bullish analysts. 14 are the (NYSE:PFE)’s ratings reports on 16 May 2018 according to StockzIntelligence Inc. On Tuesday, November 21 the stock of Pfizer Inc. (NYSE:PFE) has “Buy” rating given by BMO Capital Markets. On Wednesday, January 31 the firm has “Neutral” rating given by Credit Suisse. In Friday, December 15 report BMO Capital Markets maintained it with “Buy” rating and $39.0 target. On Monday, February 26 the stock of Pfizer Inc. (NYSE:PFE) has “Hold” rating given by Jefferies. On Tuesday, January 16 Jefferies maintained Pfizer Inc. (NYSE:PFE) rating. Jefferies has “Hold” rating and $40.0 target. In Sunday, January 28 report SunTrust maintained it with “Hold” rating and $40.0 target. On Wednesday, May 2 the firm has “Outperform” rating given by BMO Capital Markets. The company rating was maintained by Leerink Swann on Wednesday, January 31. On Friday, April 13 the rating was maintained by Jefferies with “Hold”. The company rating was downgraded by Barclays Capital on Thursday, April 5.

Pfizer Inc. (NYSE:PFE) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: